Mode
Text Size
Log in / Sign up
N/A N=105 Randomized Single-blind Prevention

Veterans Coping Long-term With Active Suicide

Suicide

Enrolled (actual)
105
Serious AEs
36.2%
Results posted
Feb 2020
Primary outcome: Primary: Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior — 0.13; 0.18; 0.14; 0.05 log(attempts) — p=.13

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Coping Long Term with Active Suicide (CLASP) (Behavioral); Safety Assessment and Follow Up Evaluation (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Aug 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior
0.13; 0.18; 0.14; 0.05; 0.06; 0.01 .13
SECONDARY
Changes in Beck Hopelessness Scale
13.65; 13.21; 9.12; 9.28; 10.06; 9.28 .79
SECONDARY
Brief Symptom Inventory
1.93; 1.98; 1.30; 1.17; 1.26; 1.23 .49
SECONDARY
World Health Organization Disability Assessment Schedule (WHODAS) II
2.58; 2.54; 2.12; 2.09; 2.17; 2.07 .96
SECONDARY
Treatment History Interview
0.12; 0.07; 0.03; 0.06; 0.04; 0.06 .62
SECONDARY
Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Ideation Severity
3.88; 4.16; 2.56; 2.47; 2.08; 1.66

Summary

The proposed study seeks to test the efficacy of an intervention to reduce suicide behaviors in Veterans. The Veterans Coping Long Term with Active Suicide Program (CLASP-VA) is an innovative, telephone-based intervention that combines elements of individual therapy, case management, and significant other/family therapy and is designed to be integrated into a VA system.

Eligibility Criteria

Inclusion Criteria

  • suicide attempt or suicidal ideation with any methods, plan, and/or intent to make a suicide attempt within 1 week of hospitalization
  • age greater than 18
  • have a telephone
  • ability to speak, read, and understand spoken English sufficiently well to complete the procedures of the study

Exclusion Criteria

  • long-term psychiatric disorder
  • diagnosis of borderline personality disorder
  • cognitive impairment which would interfere with adequate participation in the project (MMSE <20)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01894841). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search